Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

拉姆 - NMPA Drug Approval Details

Approvals/NMPA/Nateglinide Tablets

Approved

化学药品

Nateglinide Tablets

西南药业股份有限公司🇨🇳 National Medical Products Administration

Approval Date: Nov 9, 2020
Approval ID: 7LeaeEpaZ74
Company: 西南药业股份有限公司
Type: 化学药品

Approval Details

Approval Id: 7LeaeEpaZ74
Approval Number: 国药准字H20052639
Generic Name: 那格列奈片
Generic Name En: Nateglinide Tablets
Trade Name: 拉姆
Brand Name: 拉姆
Drug Type: 化学药品
Dosage Form: 片剂
Strength: 30mg
Reg Date: 2020-11-09
Company Name: 西南药业股份有限公司
Company Address: 重庆市沙坪坝区天星桥21号
Production Company Name: 西南药业股份有限公司;太极集团四川太极制药有限公司
Production Company Address: 重庆市沙坪坝区天星桥21号；四川省成都市双流区西南航空港经济开发区腾飞二路319号
Company Detail Path: /organization/xi-nan-yao-ye-gu-fen-you-xian-gong-si

Approved

Quick Info

Agency

NMPA

Country

🇨🇳

Approval Date

Nov 9, 2020

Approval ID

7LeaeEpaZ74

Type

化学药品

Back to NMPA Approvals